Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Bokstein

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Blood|April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportSigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Journal of Neuro-Oncology|August 18, 2016
Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patientsDeborah T Blumenthal, Addie Dvir, Alexander Lossos, et al.
International Journal of Oncology|February 13, 2015
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastomaBenjamin M Ellingson, Eunhee Kim, Davis C Woodworth, et al.
Plos One|December 5, 2012
Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumorsDafna Ben Bashat, Moran Artzi, Haim Ben Ami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227Jon Glass, Minhee Won, Christopher J Schultz, et al.
Neuro-Oncology|December 18, 2019
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II studyAndrew J Brenner, Katherine B Peters, James Vredenburgh, et al.
Targeted Oncology|January 22, 2018
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical ExperienceOfer Purim, Alexander Beny, Moshe Inbar, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Blood|April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportSigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Journal of Neuro-Oncology|August 18, 2016
Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patientsDeborah T Blumenthal, Addie Dvir, Alexander Lossos, et al.
International Journal of Oncology|February 13, 2015
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastomaBenjamin M Ellingson, Eunhee Kim, Davis C Woodworth, et al.
Plos One|December 5, 2012
Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumorsDafna Ben Bashat, Moran Artzi, Haim Ben Ami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227Jon Glass, Minhee Won, Christopher J Schultz, et al.
Neuro-Oncology|December 18, 2019
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II studyAndrew J Brenner, Katherine B Peters, James Vredenburgh, et al.
Targeted Oncology|January 22, 2018
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical ExperienceOfer Purim, Alexander Beny, Moshe Inbar, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Pageof 5